MedPath

Short-term efficacy evaluation of Professor Liu jing in alleviating adenoidal hypertrophy in Children prospective cohort study

Not Applicable
Conditions
Adenoidal Hypertrophy
Registration Number
ITMCTR2023000005
Lead Sponsor
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Those who meet the Western medical diagnostic criteria for pediatric adenoid hypertrophy ;
(2) Age between 3 and 10 years old;
(3) Sign the informed consent form (children aged = 8 sign independently, and children aged<8 sign on behalf of their guardians or legal representatives).

Exclusion Criteria

(1) Children with poor breathing caused by obesity, nasal polyps, deflection of nasal septum, and other reasons;
(2) Severe impact on sleep, combined with severe primary systemic diseases such as heart, brain, lung, liver, kidney, and hematopoiesis;
(3) Children with severe malnutrition, dysfunction, severe rickets, and mental illness;
(4) Those who are unable to complete auxiliary examinations and follow-ups due to various reasons

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
(Visual Analogue Scale/Score;Severity grading of nasal cavity after adenoid obstruction under fiberoptic nasopharyngoscopy examination;
Secondary Outcome Measures
NameTimeMethod
Secondary Symptom Rating Scale;Scale for evaluating other nasal manifestations under fiberoptic nasopharyngoscope;disease specific quality of life for children with obstructive sleep apnea 18 items survey(OSA-18);
© Copyright 2025. All Rights Reserved by MedPath